Cesta de la compra

Life Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love

Autor Tony Robbins

Editorial SIMON & SCHUSTER UK LTD.

Life Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love
-5% dto.    32,00€
30,40€
Ahorra 1,60€
No disponible, consulte disponibilidad
Envío gratis
España peninsular

Life Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love

Autor Tony Robbins

Editorial SIMON & SCHUSTER UK LTD.

-5% dto.    32,00€
30,40€
Ahorra 1,60€
No disponible, consulte disponibilidad
Envío gratis
España peninsular

Detalles del libro

Tony Robbins is an entrepreneur, #1 New York Times bestselling author, and philanthropist honored by Accenture as one of the top fifty business intellectuals in the world. Robbins is a leader called upon by leaders: He?s consulted and coached some of the world?s greatest athletes, entertainers, Fortune 500 CEOs, and four US presidents. Robbins is a founder, partner, or early investor in 100+ privately held businesses with combined sales exceeding $7 billion annually. Through his philanthropy and partnership with Feeding America, he has provided more than 800 million meals and is on track to provide 1 billion meals by 2025. He lives in Palm Beach, Florida.

Peter H. Diamandis, MD, is a New York Times bestselling author and the cofounder of Singularity University, Human Longevity, Inc., Celularity, Inc., and founder of Bold Capital Partners. He is the founder and Executive Chairman of XPRIZE. Diamandis has degrees in molecular genetics and aerospace engineering from MIT and an MD from Harvard Medical School.

Robert Hariri, MD, PhD, is an accomplished neurosurgeon, biomedical scientist, and serial entrepreneur in biomedicine and aerospace. He is the cofounder and chairman of Celularity, Inc. Before Celularity, Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, acquired by Celgene Corporation, and cofounded the genomic-based health intelligence company Human Longevity, Inc.